In rats, bicuculline given into the supraoptic nucleus significantly increased oxytocin release within the nucleus under basal conditions and during stress.
In plain wordsIn rats, blocking GABA receptors in one brain area raised the release of the body's own oxytocin inside that area.
- Peptide
- Oxytocin
- Outcome
- IncreaseOxytocin release within the SON after GABAA antagonist bicuculline
- Study
ratn: not reported in source
Male Wistar rats, microdialysis and electrophysiology- Comparator
- Basal values
- Outcome group
- Brain and neuronal activity · Nervous system and cognition
Source sentences
This approach caused a significant increase in the release of OXT both within the SON and into the blood under basal conditions and during stress (up to 300 and 200%, respectively; P < 0.05 vs. basal values)
2 context sentences(design, population, supporting numbers)
To further investigate the regulatory mechanisms underlying this dissociated release, we exposed male Wistar rats to a 30-min social defeat and monitored release of the inhibitory amino acids gamma amino butyric acid (GABA) and taurine within the hypothalamic supraoptic nucleus (SON) using microdialysis.
To reveal the physiological significance of centrally released GABA, the specific GABAA-receptor antagonist bicuculline (0.02 mm) was administered into the SON via retrodialysis.
This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.